Private equity firm Advent International (Advent) has signed a definitive agreement to acquire a majority interest in Bharat Serums and Vaccines Limited for an undisclosed sum. Bharat Serums is a biopharmaceutical player in women’s healthcare, assisted reproductive treatment, critical care and emergency medicine in India and emerging markets. — Business Standard

Khaitan & Co advised Bharat Serums and Vaccines Limited and its promoters, the Daftary family, led by a core transaction team of partner Haigreve Khaitan, partner Sameer Sah, senior associate Ayush Nanda and associate Aman Anand, also with assistance from the following: corporate aspects principal associate Purti Minawala, senior associate Avantika Govil, associate Kanika Mathew, associate Maitreya Subramaniam and consultant Subramanian Ramaswamy; employment aspects partner Anshul Prakash, principal associate Deepak Kumar, associate Abhisek Choudhury, associate Deeksha Malik and associate Kosheel Gupta; litigation aspects principal associate Manavendra Mishra and senior associate Zacarias Joseph; real estate aspects partner Harsh Parikh and principal associate Abhiraj Gandhi.

2019-11-18

Deal value: Confidential

{incomplete}